Please assess the completion status of the following clinical trial:

Trial Title: CP-690-550 Ointment For Chronic Plaque Psoriasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Mild to moderate chronic plaque psoriasis (psoriasis vulgaris), with the duration of at least 6 months;~* A target plaque of at least 9 sq. cm.~Exclusion Criteria:~* Demonstrates rebound or flare of chronic plaque psoriasis;~* Non plaque form of psoriasis;~* Currently have or history of psoriatic arthritis;~* Current drug induced psoriasis;~* Currently on systemic therapy or was on systemic therapy for psoriasis within the previous 6 months;~* Currently on phototherapy for psoriasis or was on phototherapy within the previous 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Treatment Group A (Type: EXPERIMENTAL): None
- Treatment Group B (Type: PLACEBO_COMPARATOR): None
- Treatment Group C (Type: EXPERIMENTAL): None
- Treatment Group D (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).